The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The transition metals copper and iron in neurodegenerative diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 2×
“Supporting this hypothesis, Clioquinol (CQ), a metal-binding compound that crosses the blood-brain barrier, reduced the number of senile plaques in the brain of transgenic mice [73], delayed cognitive impairment and decreased plasma Abeta levels in AD patients [74].”
BackgroundDexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149 · cited 5×
“Total Cu content is reduced in the SNpc [92] and the caudate nucleus [59], but not in the cerebellum, globus pallidus, putamen or the dorsolateral prefrontal cortex [94] from PD brains.”
BackgroundInfluentialRitchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988 · cited 2×
“Supporting this hypothesis, Clioquinol (CQ), a metal-binding compound that crosses the blood-brain barrier, reduced the number of senile plaques in the brain of transgenic mice [73], delayed cognitive impairment and decreased plasma Abeta levels in AD patients [74].”
BackgroundAge-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968 · cited 2×
“[231] G.”
Background
Cited by
Copper: toxicological relevance and mechanisms
Gaetke, L. M., Chow-Johnson, H. S., & Chow, C. K. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1355-y · Cited by 743
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Lee, W.-H., Loo, C.-Y., Bebawy, M., Luk, F., Mason, R., & Rohanizadeh, R. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040002 · Cited by 537
Metabolism and functions of copper in brain
Scheiber, I. F., Mercer, J. F. B., & Dringen, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.01.002 · Cited by 506
Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases)
Kozlowski, H., Luczkowski, M., Remelli, M., & Valensin, D. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.013 · Cited by 437
Copper Dyshomeostasis in Neurodegenerative Diseases—Therapeutic Implications
Gromadzka, G., Tarnacka, B., Flaga, A., & Adamczyk, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239259 · Cited by 339
Copper and Its Complexes in Medicine: A Biochemical Approach
Iakovidis, I., Delimaris, I., & Piperakis, S. M. (2011) · Molecular Biology International · doi:10.4061/2011/594529 · Cited by 336
Guzior, N., Wi.eckowska, A., Panek, D., & Malawska, B. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141106122628 · Cited by 323
“Thus, the modulation of the level of these biometals in the brain is also a potential therapeutic strategy for treating AD [167-171].”
BackgroundMercury Toxicity and Neurodegenerative Effects
Carocci, A., Rovito, N., Sinicropi, M. S., & Genchi, G. (2014) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/978-3-319-03777-6_1 · Cited by 315
Ramos, P., Santos, A., Pinto, N. R., Mendes, R., Magalhães, T., & Almeida, A. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2013.08.001 · Cited by 221
Copper and Copper Proteins in Parkinson’s Disease
Montes, S., Rivera-Mancia, S., Diaz-Ruiz, A., Tristan-Lopez, L., & Rios, C. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/147251 · Cited by 203
“Alterations in transition metal storage, transport, and cellular handling have gained attention in neurodegenerative diseases [11], particularly as early postmortem reports showed iron accumulation and decreased copper levels in brains from Parkinson’s disease patients [12, 13].”
BackgroundSelf-citationHigher iron in the red nucleus marks Parkinson's dyskinesia
Lewis, M. M., Du, G., Kidacki, M., Patel, N., Shaffer, M. L., Mailman, R. B., & Huang, X. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.025 · Cited by 84
“Iron in the remaining SN cells also might be compensatory to the primary cell damage (Rivera-Mancia et al., 2010).”
Martínez-Hernández, R., Montes, S., Higuera-Calleja, J., Yescas, P., Boll, M.-C., Diaz-Ruiz, A., & Rios, C. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0535-x · Cited by 34
“The actual mechanism accounting for iron accumulation in the brains of PD patients is still unknown; however, proteins related to transport, storage and mobilization of the metal may be involved [ 21 ].”
BackgroundSelf-citation
Metadata
- Authors
- Rivera-Mancía, S., Pérez-Neri, I., Ríos, C., Tristán-López, L., Rivera-Espinosa, L., & Montes, S.
- Venue
- Chemico-Biological Interactions
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 186
- Issue
- 2
- Pages
- 184-199
- ISSN
- 0009-2797 (ISSN-L)
- OpenAlex
- W1963698191
- Cited by
- 244
- References
- 52
- FWCI
- 19.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.